Actively Recruiting
Exploring Vancomycin Disposition in Neonates
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-12
120
Participants Needed
1
Research Sites
561 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Vancomycin is already used for decades in neonates. However, there are remaining questions concerning vancomycin disposition in this population. The purpose of this study is first of all to perform a paired analysis of serum vancomycin concentrations using an immunoassay versus a reference liquid chromatography-tandem mass spectrometry method. Secondly, we aim to determine vancomycin protein binding and its covariates in neonates.
CONDITIONS
Official Title
Exploring Vancomycin Disposition in Neonates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Neonates admitted to the Neonatal Intensive Care Unit who are receiving vancomycin treatment by medical decision
- Informed consent given by parents
You will not qualify if you...
- Not receiving vancomycin therapy
- No signed informed consent available
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
Research Team
A
Anne Smits, MD
CONTACT
K
Karel Allegaert, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here